Open Access
Volume 18, Number 2, May 2011
Page(s) 121 - 126
Published online 15 May 2011
  1. Antunes J., Fernandes A., Borrego L.M., Leiria-Pinto P. & Cavaco J. Cystic fibrosis, atopy, asthma and ABPA. Allergol Immunopathol, 2010, 38, 278–284. [CrossRef] [Google Scholar]
  2. Benfield T.L., Lundgren B., Shelhamer J.H. & Lundgren J.D. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-I release from a human alveolar epithelial cell line. European Journal of Clinical Investigation, 1999, 29, 717–22. [CrossRef] [PubMed] [Google Scholar]
  3. Calderón E.J., Regordan C., Medrano F.J., Ollero M. & Varela J.M. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet, 1996, 347, 977. [CrossRef] [Google Scholar]
  4. Calderón E., de la Horra C., Medrano F.J., López-Suárez A., Montes-Cano M.A., Respaldiza N., Elvira-González J., Martín-Juan J., Bascuñana A. & Varela J.M. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. European Journal of Clinical Microbiology & Infectious Diseases, 2004, 23, 545–549. [Google Scholar]
  5. Calderón E.J, Rivero L., Respaldiza N., Morilla R., Montes-Cano M.A., Friaza V., Muñoz-Lobato F., Varela J.M., Medrano F.J. & de la Horra C. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clinical Infectious Diseases, 2007, 45, e17–e19. [Google Scholar]
  6. Calderón E.J. Epidemiology of Pneumocystis infection in Human. Journal de Mycologie Médicale, 2009, 19, 270–275. [CrossRef] [Google Scholar]
  7. Calderón E.J., Gutiérrez-Rivero S., Durand-Joly I. & Deicas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Review of Anti-infective Therapy, 2010, 8, 259–262. [CrossRef] [PubMed] [Google Scholar]
  8. Cano S., Capote F., Pereira A., Calderón E. & Castillo J. Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest, 1993, 104, 376–381. [CrossRef] [PubMed] [Google Scholar]
  9. Chapman K.R., Mannino D.M., Soriano J.B., Vermeire P.A., Buist A.S., Thun M.J., Connell C., Jemal A., Lee T.A., Miravitlles M., Aldington S. & Beasley R. Epidemiology and costs of chronic obstructive pulmonary disease. European Respiratory Journal, 2006, 27, 188–207. [CrossRef] [Google Scholar]
  10. Christensen P.J., Preston A.M., Ling T., Du M., Fields W.B., Curtis J.L. & Beck J.M. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infection and Immunity, 2008, 76, 3481–3490. [CrossRef] [PubMed] [Google Scholar]
  11. de la Horra C., Varela J.M., Fernández-Alonso J., Medrano F.J., Respaldiza N., Montes-Cano M.A. & Calderón E.J. Association between human-Pneumocystis infection and small-cell lung carcinoma. European Journal of Clinical Investigation, 2004, 34, 229–235. [CrossRef] [PubMed] [Google Scholar]
  12. du Bois R.M., Goh N., Mcgrath D. & Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? Journal of Internal Medicine, 2003, 253, 4–17. [CrossRef] [PubMed] [Google Scholar]
  13. Egan J.J., Woodcock A.A. & Stewart J.P. Viruses and idiopathic pulmonary fibrosis. European Respiratory Journal, 1997, 10, 1433–1437. [CrossRef] [Google Scholar]
  14. Friaza V., de la Horra C., Rodríguez-Domínguez M.J., Martínjuan J., Cantón R., Calderón E.J. & Del Campo R. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. Journal of Microbiological Methods, 2010, 82, 98–101. [CrossRef] [PubMed] [Google Scholar]
  15. Gal S.L., Héry-Arnaud G., Ramel S., Virmaux M., Damiani C., Totet A. & Nevez G. Pneumocystis jirovecii and cystic fibrosis in France. Scandinavian Journal of Infectious Diseases, 2010, 42, 225–227. [CrossRef] [PubMed] [Google Scholar]
  16. Gan W.Q., Man S.F.P., Senthilselvan A. & Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax, 2004, 59, 574–580. [CrossRef] [PubMed] [Google Scholar]
  17. Krajicek B.J., Limper A.H. & Thomas C.F. Jr. Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Current Opinion in Pulmonary Medicine, 2008, 14, 228–234. [CrossRef] [PubMed] [Google Scholar]
  18. Kuper H., Adami H.O. & Trichopoulos D. Infections as a major preventable cause of human cancer. Journal of Internal Medicine, 2000, 248, 171–183. [Google Scholar]
  19. Lebron F., Vassallo R., Puri V. & Limper H. Pneumocystis carinii cell wall β-glucans initiate macrophage inflammatory responses through NFκB activation. The Journal of Biological Chemistry, 2003, 278, 25001–25008. [CrossRef] [PubMed] [Google Scholar]
  20. Lopez A.D., Shibuya K., Rao C., Mathers C.D., Hansell A.L., Held L.S., Schmid V. & Buist S. Chronic obstructive pulmonary disease: current burden and future projections. European Respirory Journal, 2006, 27, 397–412. [CrossRef] [Google Scholar]
  21. Lubis N., Baylis D., Short A., Stebbing J., Teague A., Portsmouth S., Bower M., Nelson M. & Gazzard B. Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia. Postgraduate Medical Journal, 2003, 79, 164–166. [CrossRef] [PubMed] [Google Scholar]
  22. Martín-Juan J., Gómez-Izquierdo L., Lara L., Rodríguezbecerra E., de la Horra C., Montes-Cano M.A., Respaldiza N. & Calderón E. Factores relacionados con la infección por Pneumocystis jirovecii en pacientes con enfermedad pulmonar intersticial difusa. Neumosur, 2008, 20, 65–73. [Google Scholar]
  23. Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 2005, 2, 258–266. [CrossRef] [PubMed] [Google Scholar]
  24. Montes-Cano M.A., de la Horra C., Dapena F.J., Mateos I., Friaza V., Respaldiza N., Muñoz-Lobato F., Medrano F.J., Calderón E.J. & Varela J.M. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clinical Microbiology and Infection, 2007, 13, 1008–1011. [CrossRef] [PubMed] [Google Scholar]
  25. Morris A., Kingsley L.A., Groner G., Lebedeva I.P., Beard C.B. & Norris K.A. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS, 2004a, 18, 793–798. [CrossRef] [Google Scholar]
  26. Morris A., Sciurba F.C., Lebedeva I.P., Githaiga A., Elliott W.M., Hogg J.C., Huang L. & Norris K.A. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. American Journal of Respiratory and Critical Care Medicine, 2004b, 170, 408–413. [Google Scholar]
  27. Morris A., Sciurba F.C. & Norris K.A. Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease? COPD: Journal of Chronic Obstructive Pulmonary Disease, 2008a, 5, 43–51. [CrossRef] [Google Scholar]
  28. Morris A., Wei K., Afshar K. & Huang L. Epidemiology and clinical significance of Pneumocystis colonization. The Journal of Infectious Diseases, 2008b, 197, 10–17. [Google Scholar]
  29. Nevez G., Magois E., Duwat H., Gouilleux V., Jounieaux V. & Totet A. Apparent absence of Pneumocystis jirovecii in healthy subjects. Clinical Infectious Diseases, 2006, 42, e99–e101. [CrossRef] [Google Scholar]
  30. Peterson J.C. & Cushion M.T. Pneumocystis: not just pneumonia. Current Opinion in Microbiology, 2005, 8, 393–398. [CrossRef] [PubMed] [Google Scholar]
  31. Pisani P., Parkin D.M., Muñoz N. & Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiology, Biomarkers & Prevention, 1997, 6, 387–400. [Google Scholar]
  32. Prévost M.C., Escamilla R., Aliouat E.M., Ceré N., Coudert P. & Dei-Cas E. Pneumocystosis pathophysiology. FEMS Immunology and Medical Microbiology, 1998, 28, 123–128. [CrossRef] [Google Scholar]
  33. Respaldiza N., Montes-Cano M.A., Dapena F.J., de la Horra C., Mateos I., Medrano F.J., Calderón E. & Varela J.M. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain. Clinical Microbiology and Infection, 2005, 11, 1012–1015. [CrossRef] [Google Scholar]
  34. Rice W.R., Singleton F.M., Linke M.J. & Walzer P.D. Regulation of surfactant phosphatidilcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. The Journal of Clinical Investigation, 1993, 92 (6), 2778–2782. [CrossRef] [PubMed] [Google Scholar]
  35. Rivero L., de la Horra C., Montes-Cano M.A., Rodríguezherrera A., Respaldiza N., Friaza V., Morilla R., Gutiérrez S., Varela J.M., Medrano F.J. & Calderón E.J. Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerging Infectious Diseases, 2008, 14, 1116–1118. [CrossRef] [PubMed] [Google Scholar]
  36. Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. The New England Journal of Medicine, 2005, 352, 1992–2001. [CrossRef] [PubMed] [Google Scholar]
  37. Shimizu Y., Sunaga N., Dobashi K., Fueki M., Fueki N., Makino S. & Mori M. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infectious Diseases, 2009, 9, 47. [Google Scholar]
  38. Sing A., Geiger A.M., Hogardt M. & Heeseman J. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. Journal of Clinical Microbiology, 2001, 39, 2717–2718. [CrossRef] [PubMed] [Google Scholar]
  39. Sing A., Schmoldt S., Laubender R.P., Heesemann J., Sing D. & Wildner M. Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors. Clinical Microbiology and Infection, 2009, 15, 957–960. [CrossRef] [Google Scholar]
  40. Stein C.R., Poole C., Kazanjian P. & Meshnick S.R. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerging Infectious Diseases, 2004, 10, 1760–1765. [CrossRef] [PubMed] [Google Scholar]
  41. Thomas C.F. & Limper A.H.. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nature Reviews Microbiology, 2007, 5, 298–308. [CrossRef] [PubMed] [Google Scholar]
  42. Varela J.M., Regordán C., Medrano F.J., Respaldiza N., de la Horra C., Montes-Cano M.A. & Calderón E.J. Climatic factors and Pneumocystis jirovecii infection in southern Spain. Clinical Microbiology and Infection, 2004, 10, 770–772. [CrossRef] [Google Scholar]
  43. Vidal S., de la Horra C., Martín J., Montes-Cano M.A., Rodríguez E., Respaldiza N., Rodríguez F., Varela J.M., Medrano F.J. & Calderón E.J. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clinical Microbiology and Infection, 2006, 12, 231–235. [Google Scholar]
  44. Wissmann G., Morilla R., Friaza V., Calderón E. & Varela J.M. El ser humano como reservorio de Pneumocystis. Enfermedades Infecciosas y Microbiología Clínica, 2010, 28, 38–43. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.